Showing results (501-510 of 599) with videos related to

Sort By:
Pageof 60
Arthritis & Rheumatology (Hoboken, N.J.)|May 22, 2018
Brief Report: Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group StudyVeronika K Jaeger, Gabriele Valentini, Eric Hachulla, et al.
Annals of the Rheumatic Diseases|February 3, 2011
EUSTAR biobanking: recommendations for the collection, storage and distribution of biospecimens in scleroderma researchChristian Beyer, Jörg H W Distler, Yannick Allanore, et al.
Annals of the Rheumatic Diseases|March 10, 2012
Evidence for caveolin-1 as a new susceptibility gene regulating tissue fibrosis in systemic sclerosisMirko Manetti, Yannick Allanore, Mohamad Saad, et al.
The Journal of Rheumatology|December 3, 2013
Prevalence, correlates and outcomes of gastric antral vascular ectasia in systemic sclerosis: a EUSTAR case-control studyEtienne Ghrénassia, Jérome Avouac, Dinesh Khanna, et al.
Lancet (London, England)|May 10, 2016
Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trialDinesh Khanna, Christopher P Denton, Angelika Jahreis, et al.
The Journal of Rheumatology|November 3, 2011
Polymorphisms in the interleukin 4, interleukin 13, and corresponding receptor genes are not associated with systemic sclerosis and do not influence gene expressionJasper C A Broen, Phillipe Dieude, Madelon C Vonk, et al.
NPJ Genomic Medicine|October 5, 2022
Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosisMartin Kerick, Marialbert Acosta-Herrera, Carmen Pilar Simeón-Aznar, et al.
Rheumatology (Oxford, England)|November 5, 2019
Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group studyVeronika K Jaeger, Mohammed Tikly, Dong Xu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 14, 2025
Distinct effects of complement C4A and C4B copy number in Systemic Sclerosis serological and clinical subtypesJavier Martínez-López, Carlos Rangel-Peláez, Inmaculada Rodriguez-Martin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 26, 2016
The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic SclerosisDinesh Khanna, Veronica J Berrocal, Edward H Giannini, et al.
Pageof 60